APA (7th ed.) Citation

I, C., M, H., L, B., I, A., L, D., A, H., . . . D, F. (2026). Umbilical cord mesenchymal stromal cells for respiratory complications of COVID-19 infection (ProTrans): Phase II randomized clinical trial. Cytotherapy, 28(7), 102775. https://doi.org/10.1016/j.jcyt.2026.102775

Chicago Style (17th ed.) Citation

I, Colmegna, et al. "Umbilical Cord Mesenchymal Stromal Cells for Respiratory Complications of COVID-19 Infection (ProTrans): Phase II Randomized Clinical Trial." Cytotherapy 28, no. 7 (2026): 102775. https://doi.org/10.1016/j.jcyt.2026.102775.

MLA (9th ed.) Citation

I, Colmegna, et al. "Umbilical Cord Mesenchymal Stromal Cells for Respiratory Complications of COVID-19 Infection (ProTrans): Phase II Randomized Clinical Trial." Cytotherapy, vol. 28, no. 7, 2026, p. 102775, https://doi.org/10.1016/j.jcyt.2026.102775.